Fennec Pharmaceuticals (FENC) Cash from Operations (2010 - 2025)
Fennec Pharmaceuticals' (FENC) quarterly Cash from Operations came in at 5962000.0 in Q4 2025, down 304.48% YoY from 2915722.63 in Q4 2024, and down 499.33% on a QoQ basis from 1493000.0 in Q3 2025.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Cash from Operations (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Cash from Operations data on file, last reported at 5962000.0 in Q4 2025.
- Quarterly Cash from Operations fell 304.48% year-over-year to 5962000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 12473000.0 (down 146.23% YoY) and the FY2025 annual result came in at 12473000.0, down 146.23% from the prior year.
- Cash from Operations slipped to 5962000.0 in Q4 2025, from 1493000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 39047000.0 in Q1 2024 to a low of 8387000.0 in Q2 2024.
- A 5-year average of 1745800.0 and a median of 3639500.0 in 2021 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations surged 800.14% — and 2025, when it tumbled 304.48%.
- Tracing FENC's Cash from Operations over 5 years: stood at 3245000.0 in 2021, then sank by 109.61% to 6802000.0 in 2022, then rose by 28.55% to 4860000.0 in 2023, then surged by 69.67% to 1474000.0 in 2024, then plunged by 304.48% to 5962000.0 in 2025.
- The last three Cash from Operations figures came in at 5962000.0 (Q4 2025), 1493000.0 (Q3 2025), and 3686000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -5.96 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | -3.69 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | -2.21 Mn |
| Jun 30, 2024 | -8.39 Mn |
| Mar 31, 2024 | 39.05 Mn |
| Dec 31, 2023 | -4.86 Mn |
| Sep 30, 2023 | -2.76 Mn |
| Jun 30, 2023 | -3.95 Mn |
| Mar 31, 2023 | -5.58 Mn |
| Dec 31, 2022 | -6.80 Mn |
| Sep 30, 2022 | -5.01 Mn |
| Jun 30, 2022 | -3.39 Mn |
| Mar 31, 2022 | -2.86 Mn |
| Dec 31, 2021 | -3.25 Mn |
| Sep 30, 2021 | -2.96 Mn |
| Jun 30, 2021 | -4.43 Mn |
| Mar 31, 2021 | -3.59 Mn |